Clinical Trials for Kidney Transplant Rejection

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

NCT ID: NCT07006532

This clinical trial is studying the use of a medication called tocilizumab to treat a specific type of kidney transplant rejection known as chronic active antibody-mediated rejection (CAMR). CAMR i...

Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

NCT ID: NCT06126380

Using MSCs for Chronic Active Antibody Mediated Rejection

NCT ID: NCT07005687

This clinical trial is studying the use of mesenchymal stem cells (MSCs) as a treatment for patients who have experienced chronic active antibody-mediated rejection (AMR) after receiving a kidney t...

Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

NCT ID: NCT05987527

Trifecta-Kidney cfDNA-MMDx Study

NCT ID: NCT04239703

The Trifecta-Kidney cfDNA-MMDx Study is a clinical trial focused on understanding kidney transplant rejection. Specifically, the study aims to see how levels of a specific type of DNA found in the ...

Impact of the Microbiota on the Likelihood of Renal Graft Rejection

NCT ID: NCT04736381

This clinical trial is investigating how the gut bacteria in our bodies may affect the likelihood of kidney transplant rejection. The researchers are specifically looking for a certain bacterial pa...

Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients

NCT ID: NCT04702022

This clinical trial is studying a new way to diagnose and manage kidney transplant rejection, specifically focusing on "subclinical" rejection, which means rejection that happens without obvious sy...

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

NCT ID: NCT06918990

This clinical trial is looking at a new treatment option for patients who are experiencing kidney transplant rejection, known as Antibody-Mediated Rejection (ABMR). The study will test two medicati...

GEnomic Medicine in Kidney Transplantation Study

NCT ID: NCT06365411

The GEnomic Medicine in Kidney Transplantation Study is a research trial aimed at understanding how certain genetic differences between kidney donors and recipients can affect the success of kidney...

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

NCT ID: NCT05285878

Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients

NCT ID: NCT06852625

The ATDC-PICI study is a clinical trial designed to investigate a new treatment called Autologous Tolerogenic Dendritic Cells (ATDC) for people who are highly sensitized and are waiting for a kidne...

PRObiotics for KIdney Transplantation

NCT ID: NCT06825117

AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

NCT ID: NCT05432765

The AIIM Trial is a study aimed at improving kidney transplant care by using a new approach called Phenotypic Precision Medicine (PPM). This method combines computer technology with medical knowled...

Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients

NCT ID: NCT06025240

This clinical trial is looking at a new blood test that aims to detect specific antibodies in kidney transplant patients. These antibodies can develop after a transplant and can cause damage to the...

Australian Genomics Of Chronic Allograft Dysfunction Study

NCT ID: NCT06314230

The Australian Genomics of Chronic Allograft Dysfunction (AUSCAD) study is a research project focused on understanding kidney transplant rejection and complications. It aims to learn more about why...

Tacrolimus Exposure in Kidney Transplantation

NCT ID: NCT06348446

This clinical trial is studying how much of the medication tacrolimus is needed to help prevent kidney transplant rejection in the early months after surgery. Tacrolimus is an important drug that h...

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

NCT ID: NCT06291103

The BELA-M-R trial is studying a condition called antibody-mediated rejection (ABMR) in kidney transplant patients, particularly focusing on a specific type known as subclinical ABMR (sABMR). This ...

Reduced-dose Alemtuzumab for Kidney Transplant Rejection

NCT ID: NCT06100965

This clinical trial is looking at a treatment called alemtuzumab, which is used to help prevent kidney transplant rejection, especially in patients who have experienced severe rejection or have not...

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

NCT ID: NCT04773392

This clinical trial is looking at a new way to prevent kidney transplant rejection in patients who have just received a kidney. Researchers want to see if using a medication called EnvarsusXR, take...

Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation

NCT ID: NCT05600634

This clinical trial is studying a new method to help detect if a kidney transplant is being rejected by the body. Researchers are looking at using small skin grafts taken from the same donor as the...